A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)

2020 ◽  
Author(s):  
Hajime Asahina ◽  
Kentaro Tanaka ◽  
Satoshi Morita ◽  
Makoto Maemondo ◽  
Masahiro Seike ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Mutated

scholarly journals A phase II study of first-line low-dose afatinib in patients with EGFR mutated non-small-cell lung cancer (KTORG1402)

2018 ◽  
Vol 29 ◽  
pp. vii58
Author(s):  
Takehiro Okuno ◽  
Toshihide Yokoyama ◽  
Hiroshige Yoshioka ◽  
Daichi Fujimoto ◽  
Katsuya Hirano ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Low Dose ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Egfr Mutated

A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2006 ◽  
Vol 54 (1) ◽  
pp. 57-62 ◽  
Author(s):  
Jung Han Kim ◽  
Dong Hun Lee ◽  
Hyun Chun Shin ◽  
Jung Hye Kwon ◽  
Joo Young Jung ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Split Dose
Sign in / Sign up

Export Citation Format

Share Document